Tech Company Financing Transactions

DNA Script Funding Round

Catalio Capital Management, Coatue Management and Agilent Technologies participated in a $165 million Series C capital raise for DNA Script. This venture round was announced on 10/28/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

650 Gateway Blvd.
San Francisco, CA 94080
USA

Phone

(650) 457-0844

Website

www.dnascript.com

Email Address

Not Recorded

Overview

DNA Script is a pioneering life sciences technology company developing a new, faster, more powerful and versatile way to design and manufacture nucleic acids. By putting DNA synthesis back in the lab, DNA Script aims to transform life sciences research through innovative technology that gives researchers unprecedented control and autonomy.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Donald Kania

        

Chief Executive Officer

Thomas Ybert

        

Chief Operating Officer

Sylvain Gariel

        

Browse more venture capital transactions:

Prev: 10/28/2021: Logicbroker venture capital transaction
Next: 10/28/2021: Torpago venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary